OncoGenex Pharmaceuticals CEO Richard Stewart's 2020 pay jumps 30% to $1M
OncoGenex Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: March 30, 2021
OncoGenex Pharmaceuticals reported fiscal year 2020 executive compensation information on March 30, 2021.
In 2020, three executives at OncoGenex Pharmaceuticals received on average a compensation package of $897K, a 41% increase compared to previous year.
Average pay of disclosed executives at OncoGenex Pharmaceuticals
Richard Stewart, Chief Executive Officer, received $1M in total, which increased by 30% compared to 2019. 46% of Stewart's compensation, or $474K, was in salary. Stewart also received $226K in non-equity incentive plan and $333K in option awards.
John Bencich, Chief Executive Officer, received a compensation package of $884K, which increased by 55% compared to previous year. 48% of the compensation package, or $421K, was in salary.
Cindy Jacobs, Chief Medical Officer, earned $774K in 2020, a 33% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 30, 2021.